| Deal Information |
|
||||
| Credit & Investment Research |
|
||||
| Market Research |
|
||||
| News |
|
||||
ESP Pharma Inc acquires Centocor Inc-Retavase US & from Johnson & Johnson Inc
|
US - ESP Pharma Inc acquired the Retavase US and Canadian rights of Centocor Inc, a biotechnology company, from Johnson & Johnson Inc.…
|
|
Copyright © 2012 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.